FA Bio
FungiAlert is a device that would allow for the early detection of these types of plant pathogens, by detecting the spores of Phytophthora before they infect the plant. It will be the only device in the market for monitoring the health of soil and irrigation water, alerting the user to the risk of infection, helping to dramatically decrease plantloss due to disease.
$6.70M
Latest Funding
Venture Round
Latest Funding Stage
2024-01-09
Funding Date
26
Employees
United Kingdom
Location
Harpenden, Hertford
City & State
Sales-Ready Summary
FA-BIO recently secured $6.7M in venture funding and utilizes WordPress along with SEO and analytics tools, making them a potential target for vendors offering WordPress plugins, SEO optimization services, or marketing analytics platforms.
Key Contacts
Open Positions
View Careers PageHiring For
Similar Startups
Eikon Therapeutics
Eikon Therapeutics is a biopharmaceutical company that focuses on developing innovative technologies for drug discovery. The company utilizes advanced live-cell resolution microscopy and engineering to identify and create new therapeutic candidates. Eikon Therapeutics aims to enhance the understanding of biological processes at a cellular level,supporting targeted treatment development.
Arsenale Bioyards
Arsenale is transforming biomanufacturing with a proprietary end-to-end platform that integrates advanced hardware, AI-driven software, and precision fermentation. Designed to bridge the gap from lab-scale innovation to industrial-scale production, Arsenale enables industries like food, chemicals, and materials to seamlessly develop and scalebio-based alternatives to petrochemicals and animal-derived products.
EvidenceHunt
EvidenceHunt is an AI-powered research assistant developed by medical professionals for healthcare research. Our focus is on delivering tools that streamline gathering and analyzing clinical evidence. With features like AI Chat for interactive queries and comprehensive Direct Search options, EvidenceHunt allows precise data retrieval andanalysis.
Avitia
Avitia improves cancer treatment via advanced molecular testing solutions. Avitia offer testing tools for use on-site, bioinformatics driven by AI, and actionable insights aimed at enhancing patient outcomes. Avitia offerings comprise pre-prepared NGS panels, simplified reporting mechanisms, and cooperative diagnostic platforms.